Preclinical vs Phase 1 — Metabolic Deal Valuation Comparison

Preclinical Median Upfront

$122M

Total: $1.6B

Phase 1 Median Upfront

$365M

Total: $2.9B

Stage Premium

83%

Phase 1 premium over Preclinical

Preclinical Royalties

6.7%-13.4%

vs Phase 1: 10.7%-20.1%

Model Your Deal

Market Analysis

The Preclinical to Phase 1 transition in metabolic represents a significant value inflection point. Phase 1 deals carry a median total deal value of $2.9B compared to $1.6B at Preclinical, a 83% premium reflecting clinical de-risking. Upfront payments increase from $122M to $365M.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

What is the deal value premium from Preclinical to Phase 1 in metabolic?

Phase 1 metabolic deals command a 83% premium over Preclinical in total deal value ($2.9B vs $1.6B). Upfronts increase from $122M to $365M, reflecting the de-risking value of clinical progression.

How do deal structures differ between Preclinical and Phase 1 in metabolic?

Preclinical deals are more milestone-weighted (92% milestones), reflecting higher clinical risk. Phase 1 deals shift toward higher upfront allocations (12% upfront) as clinical de-risking reduces the need for contingent milestone structures.

When is the optimal time to license a metabolic asset?

The optimal licensing window depends on strategic priorities. Preclinical assets offer lower entry cost for licensees, while Phase 1 assets provide more certainty. The 83% premium from Preclinical to Phase 1 reflects the value created by clinical data, making the transition point critical for deal timing.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating

Preclinical vs Phase 1 — Metabolic Deal Valuation Comparison

Market Analysis

Full Benchmark Analysis

Customize these benchmarks for your asset

Frequently Asked Questions

Full Benchmark Analysis

Related Benchmarks

Preclinical Metabolic Deals

Phase 1 Metabolic Deals

Phase 2 Deal Benchmarks

Ready to Calculate Your Deal Terms?